ARK Investment Management REGENERON PHARMACEUTICALS ownership

REGENERON PHARMACEUTICALS's ticker is REGN and the CUSIP is 75886F107. A total of 177 filers reported holding REGENERON PHARMACEUTICALS in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

ARK Investment Management ownership history of REGENERON PHARMACEUTICALS
ValueSharesWeighting
Q2 2022$37,100
-8.1%
55,811
-3.4%
0.22%
+30.4%
Q1 2022$40,350
-12.5%
57,773
-20.9%
0.17%
+20.9%
Q4 2021$46,097
-82.2%
72,993
-83.0%
0.14%
-77.7%
Q3 2021$259,106
-34.9%
428,147
-40.0%
0.62%
-16.1%
Q2 2021$398,266
-30.9%
713,048
-41.5%
0.74%
-35.3%
Q1 2021$576,743
+164.2%
1,218,970
+169.8%
1.15%
+97.2%
Q4 2020$218,278
+507523.3%
451,818
+507560.7%
0.58%
+58000.0%
Q1 2020$43
+30.3%
890.0%0.00%0.0%
Q4 2019$33
-99.7%
89
-99.8%
0.00%
-99.6%
Q3 2019$11,116
+24.2%
40,073
+40.1%
0.24%
+8.0%
Q2 2019$8,950
+64.7%
28,593
+116.0%
0.22%
+45.2%
Q1 2019$5,435
+4.5%
13,237
-4.9%
0.16%
-26.5%
Q4 2018$5,199
-44.6%
13,921
-40.1%
0.21%
-25.7%
Q3 2018$9,390
+46.5%
23,240
+25.1%
0.28%
+20.9%
Q2 2018$6,411
+459.9%
18,582
+458.9%
0.24%
+312.3%
Q1 2018$1,145
+10.3%
3,325
+20.4%
0.06%
-31.3%
Q4 2017$1,038
+71.3%
2,761
+123.7%
0.08%
-29.7%
Q2 2017$606
+127.0%
1,234
+78.8%
0.12%
+53.2%
Q1 2017$267
+17.1%
690
+10.9%
0.08%
-7.2%
Q4 2016$2286220.08%